AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC.Employment Agreement • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia
This Amended and Restated Employment Agreement (this “Employment Agreement”) entered into between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and Susan Caballa (“Executive”), as of the latest date set forth on the signature page hereto.
ALIMERA SCIENCES, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 17, 2008Rights Agreement • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of this 17th day of March, 2008, by and among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock (the “Series A Stock”) listed on Exhibit A attached hereto (the “Series A Investors”), the holders of the Company’s Series B Preferred Stock (the “Series B Stock”) listed on Exhibit B attached hereto (the “Series B Investors”), the holders of the Company’s Series C Preferred Stock (the “Series C Stock”) listed on Exhibit C attached hereto (the “Series C Investors”), those holders of the Company’s Common Stock listed on Exhibit D attached hereto (the “Common Holders”), and those holders of stock purchase warrants (the “Warrants”) to purchase shares of the Company’s Common Stock listed on Exhibit E attached hereto (the “Warrant Holders”). The Series A Stock, the Series B Stock and the Series C Stock, together shall be referred to h
OMNIBUS AMENDMENTOmnibus Amendment • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
THIS OMNIBUS AMENDMENT (the “Agreement”) is made and entered into as of August 25, 2009 between Alimera Sciences, Inc., a Delaware corporation (the “Company”) and each person or entity identified as a “Stockholder” on the signature pages hereto (each a “Stockholder” and collectively, the “Stockholders”).
Alimera Sciences, Inc. 2009 Equity Incentive Plan (As Adopted Effective on the IPO Date)Alimera Sciences Inc • October 30th, 2009 • Pharmaceutical preparations
OFFICE LEASE RUBICON IN WINDWARD 6120 WINDWARD PARKWAY ALPHARETTA, GEORGIA 30005Office Lease • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia
This agreement (“Lease”), made and entered into as of this 27 day of May, 2003, by and between Rubicon, L.C., a Georgia limited liability company (“Landlord”) and Alimera Sciences, Inc. (“Tenant”);
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , between Alimera Sciences, Inc. a Delaware corporation (the “Company”), and (“Indemnitee”).
ALIMERA SCIENCES, INC. SECOND AMENDED AND RESTATED STOCK SALE AGREEMENTStock Sale Agreement • October 30th, 2009 • Alimera Sciences Inc • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED STOCK SALE AGREEMENT (the “Agreement”) is made this 17th day of March, 2008, by and among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”), listed on the Schedule of Common Holders attached as Exhibit A hereto (the “Common Holders”), the holders of the Company’s Series A Preferred Stock, par value $0.01 per share (the “Series A Stock”), listed on Exhibit B attached hereto (the “Series A Investors”), the holders of the company’s Series B Preferred Stock, par value $0.01 share (the “Series B Stock”), listed on Exhibit C hereto (the “Series B Investors”) and the holders of the Company’s Series C Preferred Stock, par value $0.01 per share (the “Series C Stock”, and together with the Series A Stock and Series B Stock, the “Preferred Stock”), listed on Exhibit D attached hereto (the “Series C Investors” and, together with the Series A Investors and the Ser
